Parse Biosciences is a biotechnology company headquartered in Seattle, Washington, that specializes in single-cell sequencing technology. The company develops and commercializes innovative tools that enable researchers to analyze gene expression at the level of individual cells. Parse Biosciences has established itself as a notable player in the genomics and life sciences sector by offering a distinct approach to single-cell RNA sequencing that eliminates the need for specialized, expensive instrumentation traditionally required for this type of research.
The company's technology is rooted in a scientific breakthrough known as split-pool barcoding, which originated from academic research. This approach allows scientists to process and profile large numbers of cells across multiple samples in parallel, making high-throughput single-cell analysis more accessible to laboratories of varying sizes and budgets. Parse Biosciences serves a global community of researchers working in fields such as immunology, oncology, neuroscience, developmental biology, and drug discovery.
Scientific Foundation
Parse Biosciences was founded on technology developed through pioneering work in combinatorial barcoding. The core innovation, split-pool ligation-based transcriptome sequencing (often abbreviated as SPLiT-seq), enables researchers to label the RNA within individual cells without requiring the physical isolation of each cell into separate compartments. Instead of relying on microfluidic devices or droplet-based systems to partition individual cells, the method uses the cells themselves as reaction vessels.
In this process, fixed cells are distributed across multiple wells and receive a unique barcode combination through several rounds of splitting and pooling. Because each cell passes through a distinct sequence of wells, it acquires a unique combination of barcodes that identifies its transcripts during downstream analysis. This methodology drastically reduces the cost and hardware barriers associated with single-cell sequencing and allows for the analysis of extremely large numbers of cells across many samples in a single experiment.
Products and Technology
Evercode Whole Transcriptome
The Evercode Whole Transcriptome product is one of Parse Biosciences' flagship offerings. It provides researchers with a complete solution for profiling gene expression across single cells at scale. This kit-based approach allows scientists to capture the full transcriptome of individual cells, generating comprehensive data about which genes are active in each cell. The instrument-free nature of the workflow means that laboratories can perform single-cell experiments using standard equipment already found in most molecular biology labs, such as pipettes, centrifuges, and thermal cyclers.
The Evercode technology is available in different scales to accommodate a range of experimental needs, from smaller studies to very large projects involving hundreds of thousands or even millions of cells. This scalability is one of the defining features that distinguishes Parse Biosciences from competitors whose systems may be limited by the throughput of their hardware.
Evercode TCR and BCR
Parse Biosciences offers products focused on immune profiling, including solutions for sequencing T-cell receptors (TCR) and B-cell receptors (BCR). These tools are particularly valuable for immunologists and researchers studying the adaptive immune system, as they allow scientists to characterize the diversity and specificity of immune cell populations. Understanding receptor sequences at the single-cell level is important for research into autoimmune diseases, cancer immunotherapy, vaccine development, and infectious disease responses.
Gene Capture
The Gene Capture product enables researchers to focus their sequencing efforts on specific genes or panels of genes of interest. By targeting particular transcripts, scientists can achieve deeper coverage of relevant genes while reducing sequencing costs. This targeted approach is useful for studies where researchers already have hypotheses about which genes are most important to their biological questions.
Evercode Fixation
Cell fixation is a critical component of the Parse Biosciences workflow. The fixation technology allows researchers to preserve their samples at the time of collection, which decouples the moment of sample preparation from the actual sequencing experiment. This flexibility is especially valuable for clinical research and multi-site studies, as it permits samples to be collected, stored, and shipped before being processed together in a single batch. This capability helps reduce batch effects and improves the consistency of large-scale experiments.
Trailmaker Data Analysis Platform
Beyond wet-lab reagents and kits, Parse Biosciences provides software solutions to help researchers interpret their data. The Trailmaker platform is a cloud-based data analysis tool designed to make single-cell sequencing data more accessible and actionable. It offers researchers a way to process raw sequencing output, perform quality control, and conduct downstream analyses such as clustering and cell type identification without requiring extensive bioinformatics expertise. This integrated approach lowers the barrier to entry for laboratories that may not have dedicated computational biology staff.
Applications and Use Cases
Parse Biosciences technology is applied across a broad spectrum of research areas. In oncology, researchers use single-cell sequencing to understand tumor heterogeneity, characterize the tumor microenvironment, and study how cancer cells respond to treatment. In immunology, the technology helps scientists dissect the complexity of immune cell populations and their responses to disease or therapy.
Neuroscience researchers benefit from the ability to profile the diverse cell types found in the brain and nervous system, while developmental biologists use the technology to trace how cells differentiate and specialize during the development of organisms. The pharmaceutical and biotechnology industries employ these tools in drug discovery and development, using single-cell data to identify drug targets, understand mechanisms of action, and evaluate therapeutic responses.
The exceptionally high throughput of the Parse Biosciences platform has also enabled ambitious large-scale projects, including efforts to build comprehensive cell atlases that map the many cell types present in tissues and organisms.
Market Position and Differentiation
Parse Biosciences competes in the single-cell genomics market, an area that has grown rapidly as researchers increasingly recognize the value of understanding biology at cellular resolution rather than relying on bulk measurements that average signals across many cells. The company's primary point of differentiation is its instrument-free, split-pool barcoding approach, which contrasts with droplet-based and microfluidic systems that require dedicated capital equipment.
This approach offers several advantages. It removes the significant upfront cost of purchasing specialized machines, allows for greater flexibility in experimental design, and provides scalability that can accommodate very large numbers of cells and samples. By making single-cell sequencing more affordable and accessible, Parse Biosciences aims to broaden the community of researchers who can incorporate this powerful technology into their work.
Company Growth and Funding
Parse Biosciences has attracted significant investment from the venture capital and life sciences investment community, reflecting confidence in its technology and market potential. The company has used this funding to expand its product portfolio, grow its team, invest in research and development, and scale its commercial operations. The capital raised has supported the company's efforts to establish a larger presence, including investments in manufacturing and infrastructure to serve a growing global customer base.
Conclusion
Parse Biosciences occupies an important niche in the field of genomics by providing accessible, scalable, and instrument-free single-cell sequencing solutions. Through its Evercode product line, immune profiling tools, targeted gene capture capabilities, fixation technology, and the Trailmaker analysis platform, the company delivers an end-to-end workflow for researchers seeking to understand biology at the resolution of individual cells. By lowering the barriers to entry that have historically limited single-cell research, Parse Biosciences empowers a wide range of scientists to pursue discoveries in areas ranging from cancer and immunology to neuroscience and developmental biology. The company's technology continues to enable both routine studies and some of the most ambitious cell-mapping projects in modern life sciences.
